Prévost, Jérémie
Chen, Yaozong http://orcid.org/0000-0001-5380-2339
Zhou, Fei
Tolbert, William D. http://orcid.org/0000-0001-7549-9596
Gasser, Romain http://orcid.org/0000-0002-8565-1106
Medjahed, Halima
Nayrac, Manon http://orcid.org/0000-0001-5717-6232
Nguyen, Dung N.
Gottumukkala, Suneetha
Hessell, Ann J. http://orcid.org/0000-0001-7471-9366
Rao, Venigalla B. http://orcid.org/0000-0002-0777-6587
Pozharski, Edwin
Huang, Rick K.
Matthies, Doreen http://orcid.org/0000-0001-9221-4484
Finzi, Andrés
Pazgier, Marzena
Funding for this research was provided by:
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (AI148379, AI150322, AI129769, AI174908, AI129801, AI162242)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (GM56550/AI150471)
Gouvernement du Canada | Instituts de Recherche en Santé du Canada | CIHR Skin Research Training Centre (352417, 41027)
ViiV Healthcare
Article History
Received: 17 May 2023
Accepted: 12 October 2023
First Online: 23 October 2023
Competing interests
: J.P., A.F., and M.P., are inventors on U.S. patent application No. 17/762,333 related to compositions and methods based on HIV gp120 LMHS mutants, in which there are no restrictions on the publication of this manuscript data. The remaining authors declare no competing interests. The views expressed in this manuscript are those of the authors and do not reflect the official policy or position of the Uniformed Services University, US Army, the Department of Defense, or the US Government.